Gland Pharma Limited GLAND.NS · Stock Open Gland Pharma Limited in new tab
Gland Pharma Limited Analysis (GLAND.NS)
Is Gland Pharma Limited a good investment? Gland Pharma Limited (GLAND.NS) is currently trading at 2874.40 INR. Market analysts have a consensus price target of 2871.43 INR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 40.64. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Gland Pharma Limited is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is 96.42.
For income investors, Gland Pharma Limited pays a dividend yield of 0.68%. With a payout ratio of 26%, the dividend appears sustainable.
Investor FAQ
Does Gland Pharma Limited pay a dividend?
Yes, it pays an annual dividend of 20.00 INR (0.68% yield).
What asset class is Gland Pharma Limited?
Gland Pharma Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of 70.56.
Company Profile
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
| Year | Total Dividends |
|---|---|
| ▸2027 |
20.00 INR
|
| Sept. 24, 2027 (estimated) | 20.0000 |
| ▸2026 |
20.00 INR
|
| Sept. 24, 2026 | 20.0000 |
| ▸2025 |
18.00 INR
|
| Sept. 27, 2025 | 18.0000 |
| ▸2024 |
20.00 INR
|
| Sept. 9, 2024 | 20.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Gland Pharma Limited | Sep 24, 2026 | Paid | 20.0 INR |
Community Discussion